Matthew McManus

Matthew McManus

Voorzitter bij
Ansa Biotechnologies, Inc.

Vermogen: 397 471 $ op 31-05-2026

57 jaar
Health Technology
Consumer Services
Health Services

Profiel

Matthew F.
McManus
is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
01-02-2026 7.691 ( 0% ) 397 471 $ 31-05-2026

Actieve functies van Matthew McManus

BedrijvenFunctieBegin
Voorzitter 22-02-2023

Eerdere bekende functies van Matthew McManus

BedrijvenFunctieEinde
BIO-TECHNE CORPORATION Corporate Officer/Principal 01-03-2026
AZENTA, INC. Operationeel Directeur 14-10-2022
Algemeen Directeur -
Corporate Officer/Principal 02-01-2010
PROCTER & GAMBLE COMPANY Corporate Officer/Principal -
Ervaring van Matthew McManus in detail bekijken

Opleiding van Matthew McManus

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

19

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Consumer Non-Durables

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Matthew McManus